Big Rewards Await Pharma Companies with Big Data in the Cloud

Source- The plummeting costs and rising availability of genetic testing, coupled with the ubiquity of digital clinical data, are creating promising new opportunities for pharmaceutical and life sciences companies to develop innovative drugs and breakthrough precision therapies. The amount of genomic data available for research doubles in size every eight months, says Eric Banks, Senior Director of the Data Sciences and Data Engineering (DSDE) group at the Broad Institute, a collaboration between Harvard and MIT. “It’s a level of growth that for

Read more